Objective: Menopausal hot flashes are considered largely a quality-of-life issue. However, emerging research also links hot flashes to cardiovascular risk. In some investigations, this risk is particularly apparent among women using hormone therapy. The aim of this study was to determine whether a longer history of reported hot flashes over the study period was associated with greater aortic and coronary artery calcification. Interactions with hormone therapy use were examined in an exploratory fashion.
A pproximately 75% of midlife women experience hot flashes at some point during the menopausal transition. 1 Most women experience hot flashes for the several years around the final menstrual period. However, hot flashes can persist for decades. Among Women's Health Initiative (WHI) and Heart and Estrogen Replacement Study (HERS) participants, 23% to 37% of women in their 60s and 11% to 20% of women in their 70s reported hot flashes. 2, 3 Hot flashes are associated with reported sleep disruption, 4 poorer memory performance, 5 depressed mood, 6 and overall poorer quality of life. 7 Most women with menopausal symptoms, principally hot flashes, seek treatment for them. 8 Although the quality-of-life impact of hot flashes is substantial, hot flashes are generally considered to have few medical implications. However, recent findings have called this notion into question. For example, both the WHI and HERS found the greatest risk of myocardial infarction among women randomized to the hormone therapy (HT) arm who reported vasomotor symptoms at study baseline. 9, 10 Several cardiovascular risk factors, particularly obesity and smoking, are also risk factors for hot flashes. 1, 11 In the Study of Women's Health Across the Nation Heart Study, we found hot flashes to be associated with greater aortic calcification (AC) and poorer flow-mediated dilation, controlling for estradiol concentrations and traditional cardiovascular disease (CVD) risk factors. 12 AC and flow-mediated dilation can be considered markers of subclinical CVD, as they are associated with a subsequent increased risk of development of clinical CVD. 13, 14 These Study of Women's Health Across the Nation findings were among midlife women who were, on average, 50 years old. However, there is a suggestion that the greatest cardiovascular risk with HT use may be concentrated among older women with vasomotor symptoms. 9, 10 The aim of the current investigation was to examine among an older cohort of women whether prospectively measured hot flashes were associated with greater AC and coronary calcification (CAC), both of which have been prospectively linked to future clinical events. 13, 15 We evaluate this hypothesis among participants (aged 57-67 y) in the Healthy Women Study, a longitudinal study of cardiovascular risk in postmenopause. We considered history of hot flashes over the course of the study, given the extended duration over which calcification develops, with hot flash reporting at a single time point secondarily examined. Associations were examined controlling for traditional cardiovascular risk factors. Given prior evidence that associations between hot flashes and cardiovascular risk may be most apparent among HT users and women with a longer time since menopause, 9, 10 we also considered interactions by HT use and time since menopause in all models.
METHODS

Participants
The Healthy Women Study is a longitudinal study of menopause and cardiovascular risk. In 1983 In -1984 women between the ages of 42 and 50 years were recruited from Allegheny County, PA, via driver's license lists. Eligibility criteria were having menstrual bleeding within the past 3 months; having no surgical menopause; having a diastolic blood pressure less than 100 mg Hg; and not using anti-hypertensive, lipid-lowering, or psychotropic medications, thyroid hormone, insulin, or estrogens. Sixty percent of eligible women enrolled. Details of the recruitment and sample characteristics are described elsewhere. 16 At the baseline study visit, demographic, behavioral, and cardiovascular risk factors were measured. When a woman reported amenorrhea and/or HT with amenorrhea for 12 successive months, determined on postcards completed monthly, she was considered 1 year postmenopausal. Participants underwent a follow-up assessment at approximately 2, 5, and 8 years postmenopausal. Postmenopausal evaluations included assessment of hot flashes. In 1997, Healthy Women Study participants in the Pittsburgh area who had been postmenopausal for 5 years or more were invited to have an electron beam tomography (EBT) scan. A total of 351 women completed this scan. The University of Pittsburgh Institutional Review Board reviewed and approved the study procedures, and all participants provided written informed consent.
Of the 351 women who underwent EBT, 49 were excluded from this analysis because of chemotherapy (n = 3), missing AC data (n = 9), or hysterectomy (n = 37). The hysterectomized women were excluded because of their potentially differing hot flash and cardiovascular profile. 17<19 However, results from the primary analyses including these 37 women showed an identical pattern of results as reported herein (data not shown). An additional 20 women were excluded from risk factorYadjusted models because of missing data on one or more covariates (smoking, n = 2; hypertension or lipidlowering medication use, n = 1; alcohol use, n = 3; blood pressure, n = 1; low-density lipoprotein [LDL], n = 11; highdensity lipoprotein, n = 5; triglycerides, n = 7; glucose, n = 6; HT use, n = 2; and body mass index, n = 5). Thus, 302 women were included in basic models and 282 women were included in risk factorYadjusted models. Women included in the analyses were younger (mean, 62.1 vs 62.2 y; P = 0.01) and had lower fasting glucose levels (mean, 92.0 vs 94.0 mg/dL; P = 0.003) than did the excluded women.
Measures
Hot flashes
At each assessment, women reported whether they had hot flashes (yes/no) in the past 2 weeks via a standard checklist adapted from Neugarten and Kraines. 20 The duration of hot flash reporting over the course of the study (referred to as Bhot flash history[) was calculated as the proportion of total study visits that the woman attended in which she reported hot flashes (number of visits with report of hot flashes/number visits attended with nonmissing hot flash data). In secondary analyses, the hot flash report closest to the EBT scan was chosen, typically the eighth postmenopausal assessment.
Calcification
EBT was used to assess CAC and AC using a GE-Imatron C-150 Scanner (Imatron, South San Francisco, CA), as previously described. 21 During coronary scanning, 30 to 40 contiguous 3-mm-thick transverse images were obtained during maximal breathholding by using electrocardiogram triggering so that each 100-millisecond exposure was obtained during the same phase of the cardiac cycle, 80% of the R-to-R interval. During a second pass, 6-mm contiguous images of the aorta (30-ms exposure) were obtained from the aortic arch to the iliac bifurcation. Agatston calcium scores 22 were derived from these images based upon three or more contiguous pixels greater than 130 Hounsfield units detected. Scan-to-scan score reproducibility was high (interclass correlation, 0.99). 23 CAC and AC were primarily considered as continuous variables (square root transformation for AC and log transformation for CAC). However, because of their highly skewed distributions, they were considered categorically in secondary models. AC was considered in tertiles based upon the distribution given the lack of clinical cutpoints for AC (0, n = 74; 90-241, n = 119; and Q242, n = 109). CAC was dichotomized (0, n = 162; 90, n = 140). A three-level CAC categorization was also considered (0, 90-100, 9100), 24 which also showed comparable findings.
Covariates
Age was that at the EBT assessment, and time since menopause was calculated as years from menopause to the EBT assessment date. Race was self-reported at baseline in response to an open-ended question, and education was assessed as the highest level of attainment (categorized as Gcollege or Qcollege). The remaining covariates were derived from the visit closest to the EBT assessment. Marital status was categorized as married or unmarried (divorced, widowed, or never married). Current cigarette smoking was reported as yes or no. Alcohol use was self-reported and calculated as grams per day. Depressive symptoms were assessed via the Beck Depression Inventory. 25 A 24-hour food-recall interview was administered by trained nutritionists at study entry. Body mass index was calculated from measurements of height and weight (kilograms per meter squared). Blood pressure was measured by random zero sphygmomanometer. 25 Lipid-lowering and antihypertensive medication use was assessed by self-report. Total serum cholesterol, highdensity lipoprotein cholesterol, and triglyceride concentrations were determined by conventional enzymatic methods from fasting (12-h) blood samples, with LDL-cholesterol level estimated by the Friedewald equation. 26 Plasma fasting glucose level was determined by enzymatic assay (Yellow Springs glucose analyzer). HT use was assessed at each visit. HT use at the visit concurrent with the hot flash assessment (current HT use) was primarily considered, with the proportion of prior study visits attended in which HT use was reported considered in secondary analyses (oral or transdermal estrogen and progesterone, n = 122; estrogen only, n = 2; progesterone only, n = 1; other, n = 16).
Statistical analysis
Relations between hot flashes and demographic, behavioral, and physiologic variables were considered using t tests, analysis of variance, and W 2 tests. Relations between hot flashes and calcification were evaluated via linear regression and secondarily in logistic regression models. Conformation to assumption of proportionality was verified for ordinal logistic models. Covariates were selected based upon their association with the outcome at P G 0.20. Systolic blood pressure and diastolic blood pressure were not included in the same model because of their high correlation; that with the strongest association with the outcome was included. The time difference between the last hot flash assessment and EBT scan (mean [SD], 1.78 [1.85] y; range, 0-9 y) was considered as a covariate in all analyses. Two-and three-way interactions between hot flash history, HT use, and time since menopause in relation to calcification were considered. Tests were two sided (> = 0.05).
RESULTS
Participants were predominantly white and well educated and had a favorable cardiovascular risk profile because of the eligibility criteria imposed at the beginning of the Healthy Women Study (Table 1) . At the time of the EBT evaluation, most women were in their 60s and many were using HT. Women reporting hot flashes at any study visit had less education, were less likely to use HT, and had higher AC scores than did women reporting no hot flashes. Findings were similar when hot flash history was considered as a continuous variable, with the exception of a positive correlation with depressive symptoms (r = 0.12, P = 0.03). Significant associations between history of hot flashes and AC were observed in basic models, with findings attenuated with adjustment for cardiovascular risk factors (Table 2) . However, a significant interaction with current HT use (visit closest to the EBT scan) was observed (P = 0.04), with significant associations between hot flash history and AC observed among HT users. Findings were consistent when AC was considered as a tertiled variable (eg, hot flash history, odds ratio [OR], 4.32; 95% CI, 1.10-16.99; P = 0.04; HT users, covariate-adjusted models). No significant associations were observed for CAC (continuous CAC: A = 0.27, SE = 0.33, P = 0.41; categorical CAC: OR, 0.89; 95% CI, 0.48-1.66; P = 0.72; full sample, minimally adjusted models).
A threshold in the association between hot flash history and AC was apparent. HT users reporting hot flashes at 50% or more of study visits had significantly higher AC scores relative to those women reporting hot flashes at 0 to less than 50% of visits ( A = 2.12, SE = 0.80, P = 0.009, minimally adjusted models; A = 1.90, SE = 0.80, P = 0.02, risk factorYadjusted models). When AC was considered categorically, among HT users, women reporting hot flashes at 50% or more of visits had more than threefold odds of increased AC relative to women reporting hot flashes at 0 to less than 50% of visits (OR, 3.07; 95% CI, 1.26-7.48; P = 0.01, risk factorYadjusted models). Figure 1 depicts the raw AC score by history of hot flash reporting for illustrative purposes.
Several additional analyses were considered. To control for the potential impact of prior HT use, we considered the history of HT use over the study as an additional covariate in risk factorYadjusted models stratified by current HT use. Findings persisted (eg, risk factorYadjusted models, HT users, hot flash history: A = 2.61, SE = 1.23, P = 0.04). Notably, there was a high stability of HT use over the study, with current HT users at the time closest to the EBT visit using HT for most study visits (mean [SD], 78.5% [26.5%] of study visits using HT) in contrast to nonusers (mean [SD], 11.1% [21.8%] of study visits using HT). In addition, to examine how current HT users may have differed from nonusers, of all study covariates, HT users had lower LDL (HT users: mean, 123.1 mg/dL; HT nonusers: mean, 134.3 mg/dL; t = 2.72, P = 0.007) and higher triglyceride (HT users: mean, 118 mg/dL; HT nonuser: mean, 99 mg/dL; t = j3.20, P = 0.002) levels at the time closest to the EBT visit compared with nonusers. Current HT users also had a lower proportion of visits with a report of hot flashes (HT users: mean, 0.19; HT nonusers: mean, 0.38; t = 4.84, P G 0.0001), an association that was not eliminated when also controlling for prior HT use (A = j0.16, SE = 0.07, P = 0.03). Furthermore, given prior research indicating a potential effect modification of years postmenopausal in relations between hot flashes and CVD risk, 9 we also considered all two-and three-way interactions with number of years postmenopausal, HT use, and hot flash history. No significant interactions were observed. Finally, associations between hot flashes at the single visit closest to the EBT assessment and calcification were examined; none of the models were significant.
DISCUSSION
The present investigation indicated that a longer history of reported hot flashes was associated with greater AC among postmenopausal women using HT. Associations persisted when controlling for traditional cardiovascular risk factors. These findings further add to the growing literature drawing links between hot flashes and cardiovascular risk.
The present findings are largely consistent with our prior work showing significantly increased AC among middleaged women reporting hot flashes. 12 This investigation j0.59 (0.86) Data are b (SE). Model 1: age, time difference between hot flash and AC measurements. Model 2: age, race, smoking, SBP, LDL, HDL, triglycerides, fasting glucose, BMI, education, alcohol use, antihypertensive medication use, lipid-lowering medication use, years since menopause, time difference between measurements, and, for the full sample models, HT use. AC, aortic calcification; HT, hormone therapy; SBP, systolic blood pressure; LDL, low-density lipoprotein; HDL, high-density lipoprotein; BMI, body mass index. extends these findings to an older sample of women. Moreover, this investigation considered history of hot flashes over the course of this longitudinal study as opposed to earlier work examining hot flashes at a single time point. Furthermore, unlike our prior work, 12 yet consistent with findings from the WHI 9 and HERS 10 showing increased cardiovascular risk with HT most clearly among women with hot flashes, associations between hot flashes and AC were observed only among women reporting HT use.
The mechanisms underlying the associations between hot flashes and AC are not fully clear, in part because of an incomplete understanding of hot flashes. Hot flashes are thought to represent primarily a thermoregulatory event. 27 However, many investigations show key cardiovascular risk factors to be associated with hot flashes, including smoking, 1 obesity, 1 and potentially, a more adverse lipid and blood pressure profile. 11 In this investigation, traditional CVD risk factors were unrelated to hot flash history, potentially because of the restricted range in these variables among these healthy women. Accordingly, findings persisted when controlling for CVD risk factors. Women with hot flashes also tend to have lower endogenous estrogen concentrations, 28 which have been linked to cardiovascular risk. 29 Reproductive hormones were not assessed here among women using HT, and therefore, we could not determine their role in the associations between hot flashes and AC among the women in whom associations were observed. Notably, in prior work, endogenous hormone concentrations have not accounted for associations between hot flashes and AC. 12 Furthermore, research has indicated a link between the potent endothelialdependent vasodilator calcitonin gene-related peptide and hot flashes. 30 Thus, multiple mechanisms, not yet fully identified, may be responsible for the observed links between hot flashes and cardiovascular risk.
Relations between hot flashes and AC were observed in HT users only. Given the documented differences between women who elect to take HT versus those who do not (eg, the healthy user bias), 31 these interactions cannot definitively be attributed to HT. Although differences between HT users and nonusers may not be fully eliminated with covariate adjustment, it is notable that the effect-modifying role of HT use persisted when controlling for demographic and CVD risk factors linked to HT use. Findings of interactions by HT use are consistent with the findings from the WHI and HERS indicating that the women with vasomotor symptoms and randomized to HT had the greatest CVD risk. 9, 10 The reasons for the interaction by HT use observed here and in other studies are not well understood. However, the interrelations between HT, hot flashes, and cardiovascular function are important to consider. First, hot flashes are often a reason women take HT. Thus, HT use may indicate women who have had severe or bothersome hot flashes. Moreover, in randomized trials, HT use has been associated with small but significantly increased risk of cardiovascular events, particularly among older women, 9, 32, 33 potentially presenting a cardiovascular challenge to women with some level of vulnerability. Thus, the relations between hot flashes, HT use, and cardiovascular risk are complex and interactive. These findings indicate that efforts to better understand relations between hot flashes and cardiovascular risk should consider a potential modifying role of HT use.
It is notable that associations were observed for the duration of hot flashes over time, rather than for hot flashes at a single time point. These findings may be understandable given the time period over which calcification develops. AC is a measure of calcified plaques in the aorta, a marker of calcified atheroma and total plaque burden, as well as arteriosclerotic remodeling of the arteries, developing over an extended period. 24 Furthermore, significant associations with hot flashes were observed for AC and not CAC. Although it is possible that these differences arose from variations in the physiology underlying relations between hot flashes and calcification in the aorta versus coronary arteries, CAC scores were low in this sample, with 54% of women with no CAC in contrast to 25% of women with no AC. This more limited range for CAC, consistent with previous findings among women, 12, 13 may have affected the ability to detect associations for CAC.
Several limitations deserve mention. Participants were primarily white, well educated, and healthy, limiting the generalizability of results. However, results are largely consistent with findings in more ethnically diverse samples. 12 As noted above, reproductive hormones deserve further investigation as a potential mechanism linking hot flashes to AC. Moreover, this study was an observational study, and any causal relations cannot be inferred. Accordingly, although the effect modification by HT is consistent with findings from randomized trials, 9, 10 it is unclear here whether the effects are attributable to HT versus some other aspect of HT users. Furthermore, excluded women were slightly older and had higher fasting glucose levels than included women, which may have affected the findings, such as a more limited range in the calcification measures observed here. Finally, hot flashes were assessed at each study visit via a questionnaire about the presence/absence of hot flashes in the past 2 weeks. These self-report instruments are vulnerable to recall and reporting biases. Although useful for identifying women with versus without hot flashes, further investigation with more detailed prospective measures of frequency, severity, and bothersomeness is warranted.
This investigation had multiple strengths. Participants were a well-characterized sample followed since the beginning of postmenopause, enabling quantification of the history of hot flash reporting measured prospectively over the course of the study. Our study included detailed calcification measures as well as multiple CVD risk factors, allowing the evaluation of AC and CAC aside from the potentially confounding impact of cardiovascular risk factors. Finally, this investigation allowed for the examination of associations between hot flashes and cardiovascular risk using a measure of subclinical CVD, allowing the detection of risk before manifestation of clinical events.
CONCLUSIONS
A longer prospectively assessed history of hot flash reporting among current HT users was associated with greater AC in this sample of postmenopausal women. These findings persisted when controlling for cardiovascular risk factors. These findings contribute to emerging research linking hot flashes and cardiovascular risk and suggest the importance of continuing the investigation of these relations and potential underlying mechanisms. If findings are replicated, this body of work would raise the possibility that hot flashes, in addition to their quality-of-life impact, may have potential medical implications in some women.
